N.WilliamsL
Science , 385 (6706), 258260.
Comparing options: tirzepatide versus other GLP-1 medications for lupus Tirzepatide is not the only GLP-1 medication available
sadly, many patients develop severe fatal outcomes because of overwhelming inflammation known as cytokine storm (248, 249), that leads to ROS-mediated cell death and tissue damage typical of RNA viruses (250)
The promise is real, but clinical readiness is not: Preclinical and early human data are compelling, but without large-scale trials, validated delivery methods, and long-term safety data, Epitalon remains an experimental peptide, one to watch closely, but not yet ready for mainstream clinical adoption
GLP-1 Agonists vs